ABOUT JOURNAL


 International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports
ISSN (online) : 2534-9821
ISSUES : 4/year
PUBLISHER : Bulgarian Association of Young Surgeons

ARTICLE TOOLS


Original Article 


EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY

Eman Arif Rahman, Sri Vitayani Muchtar, Farida Tabri, Siswanto Wahab, Anni Adriani, Arifin Seweng, Rizalinda Sjahril.

Abstract
Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae. In leprosy, cell-mediated immune responses are an important aspect of host resistance to mycobacterial infections and allegedly governed by anequilibrium between type 1 cytokines including Interleukin-12 (IL-12); with type 2 cytokines such as Interleukin-4 (IL-4). Currently, the World Health Organization (WHO) recommends 3 leprosy treatment regimens, one of them is Rifampicin Ofloxacin Minocycline (ROM). To date, studies on the effects of ROM on leprosy have been limited, none have specifically assessed the effects of ROM on specific immune systems, especially cytokines.
Methods: The study was conducted by prospective research method. The sample of this research were all multibacillary (MB) type of leprosy patients according to WHO classification who had received ROM therapy and recorded as the patient at research location and had medical record previous of interleukin-12 and interleukin-4 levels. After 12 months of ROM therapy, blood samples were collected and calculated using the Enzyme-Linked Immunosorbent Assay (ELISA) using the QuantikineŽ high sensitivity (HSv) kit.
Results: There was a statistically significant increase in IL-4 after 12 months of a 3-months-ROM therapy. In contrast, the levels of IL-12 after 12 months showed significant decreases.
Conclusions: Increased levels of IL-4 and decreased IL-12 can be caused by many factors. Therefore, further research with a closer supervision is required.

Key words: Leprosy, Rifampicin Ofloxacin Minocycline therapy, Interleukin-12, Interleukin-4


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Eman Arif Rahman
Articles by Sri Vitayani Muchtar
Articles by Farida Tabri
Articles by Siswanto Wahab
Articles by Anni Adriani
Articles by Arifin Seweng
Articles by Rizalinda Sjahril
on Google
on Google Scholar
Article Statistics
 Viewed: 25
Downloaded: 15
Cited: 0

How to Cite this Article
Pubmed Style

Rahman EA, Muchtar SV, Tabri F, Wahab S, Adriani A, Seweng A, Sjahril R. EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY. doi:10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS


Web Style

Rahman EA, Muchtar SV, Tabri F, Wahab S, Adriani A, Seweng A, Sjahril R. EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY. http://mdpub.eu//?mno=297715 [Access: May 27, 2018]. doi:10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS


AMA (American Medical Association) Style

Rahman EA, Muchtar SV, Tabri F, Wahab S, Adriani A, Seweng A, Sjahril R. EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY. doi:10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS



Vancouver/ICMJE Style

Rahman EA, Muchtar SV, Tabri F, Wahab S, Adriani A, Seweng A, Sjahril R. EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY. doi:10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS



Harvard Style

Rahman, E. A., Muchtar, S. V., Tabri, F., Wahab, S., Adriani, A., Seweng, A. & Sjahril, R. (2018) EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY. doi:10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS



Turabian Style

Rahman, Eman Arif, Sri Vitayani Muchtar, Farida Tabri, Siswanto Wahab, Anni Adriani, Arifin Seweng, and Rizalinda Sjahril. 2018. EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY. doi:10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS



Chicago Style

Rahman, Eman Arif, Sri Vitayani Muchtar, Farida Tabri, Siswanto Wahab, Anni Adriani, Arifin Seweng, and Rizalinda Sjahril. "EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY." doi:10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS



MLA (The Modern Language Association) Style

Rahman, Eman Arif, Sri Vitayani Muchtar, Farida Tabri, Siswanto Wahab, Anni Adriani, Arifin Seweng, and Rizalinda Sjahril. "EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY." doi:10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS



APA (American Psychological Association) Style

Rahman, E. A., Muchtar, S. V., Tabri, F., Wahab, S., Adriani, A., Seweng, A. & Sjahril, R. (2018) EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY. doi:10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS



Online Submission & Review

Abstracted & Indexed in:

Indexing and Abstracting Services

  • EBSCO/Proquest
  • Index Copernicus
  • DOAJ
  • Google Scholar
  • ResearchBib (Academic Research System)
  • ESJI - Eurasian Scientific Journal Index
  • ASI - Advanced Science Index

Library

  • NLB - National Library of Bulgaria
  • University of Saskatchewan
  •  

Online Resources

  • Geneva Foundation for Medical Education and Research (GFMER)
  • CrossRef
  • SciLit
  • Scipers
  • ROAD (Directory of Open Access Scholary Resources)
  • JiFactor
  • International Committee of Medical Journal Editors (ICMJE)